Cardiex Stock Performance

<div class='circular--portrait' style='background:#000000;color: #f2f2f2;font-size:3em;padding-top: 38px;;'>AMD</div>
AMDHF -- USA Stock  

USD 0.005  0.00  0.00%

The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. Let's try to break down what Cardiex's beta means in this case. the returns on MARKET and Cardiex are completely uncorrelated. Although it is extremely important to respect Cardiex historical returns, it is better to be realistic regarding the information on equity current trending patterns. The philosophy towards foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By analyzing Cardiex technical indicators, you can presently evaluate if the expected return of 0.0% will be sustainable into the future. Cardiex right now shows a risk of 0.0%. Please confirm Cardiex jensen alpha and the relationship between the value at risk and kurtosis to decide if Cardiex will be following its price patterns.

Search O TC Stock Performance


Cardiex Risk-Adjusted Performance

Over the last 30 days Cardiex has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound forward indicators, Cardiex is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Quick Ratio1.18
Fifty Two Week Low0.0050
Fifty Two Week High0.0250

Cardiex Relative Risk vs. Return Landscape

If you would invest  0.50  in Cardiex on June 14, 2020 and sell it today you would earn a total of  0.00  from holding Cardiex or generate 0.0% return on investment over 30 days. Cardiex is currently producing negative expected returns and takes up 0.0% volatility of returns over 30 trading days. Put another way, 0% of traded equities are less volatile than the company and 99% of traded equity instruments are likely to generate higher returns over the next 30 trading days.
 Daily Expected Return (%) 
      Risk (%) 

Cardiex Market Risk Analysis

Sharpe Ratio = 0.0
Good Returns
Average Returns
Small Returns
Based on monthly moving average Cardiex is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cardiex by adding it to a well-diversified portfolio.

About Cardiex Performance

To evaluate Cardiex OTC Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Cardiex generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Cardiex's stock performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Cardiex stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Cardiex's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section. Please also refer to our technical analysis and fundamental analysis pages.
CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific. CardieX Limited was incorporated in 2005 and is based in Sydney, Australia. Cardiex is traded on BATS Exchange in the United States.

Cardiex Alerts

Equity Alerts and Improvement Suggestions

Cardiex generates negative expected return over the last 30 days
Cardiex has some characteristics of a very speculative penny stock
Cardiex has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 3.29 M. Net Loss for the year was (2.64 M) with profit before overhead, payroll, taxes, and interest of 3.01 M.
Cardiex has accumulated about 535.62 K in cash with (1.49 M) of positive cash flow from operations.
Roughly 50.0% of the company shares are held by company insiders
Latest headline from Top key Players Impacting the Growth of the Cardamom Market 2026 COVID19 Impact Analysis Key Players Cardex, DS Group, MAS Enterprises, McCormick Company , , etc. InForGrowth - Owned
Please continue to Trending Equities. Please also try ETF Directory module to find actively-traded exchange traded funds (etf) from around the world.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page